SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-018814
Filing Date
2023-05-08
Accepted
2023-05-08 16:12:01
Documents
76
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fgen-20230331.htm   iXBRL 10-Q 3745608
2 EX-10.2 fgen-ex10_2.htm EX-10 42454
3 EX-10.3 fgen-ex10_3.htm EX-10 42239
4 EX-10.4 fgen-ex10_4.htm EX-10 178146
5 EX-31.1 fgen-ex31_1.htm EX-31 11713
6 EX-31.2 fgen-ex31_2.htm EX-31 11689
7 EX-32.1 fgen-ex32_1.htm EX-32 12040
  Complete submission text file 0000950170-23-018814.txt   13182275

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fgen-20230331_pre.xml EX-101.PRE 470351
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fgen-20230331_cal.xml EX-101.CAL 62425
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fgen-20230331_lab.xml EX-101.LAB 544989
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fgen-20230331.xsd EX-101.SCH 82992
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fgen-20230331_def.xml EX-101.DEF 317609
70 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20230331_htm.xml XML 2676005
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36740 | Film No.: 23897861
SIC: 2834 Pharmaceutical Preparations